To Evaluate the Safety and Efficacy of Human Derived Anti-BCMA CAR-T Injection for Subjects with R/R MM
Clinical trial NCT05302648 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05302648
- Sponsor
- Hrain Biotechnology Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-09
- Primary completion
- 2024-12-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.